financetom
Business
financetom
/
Business
/
Draganfly Up Near 13% In US Pre-market After Announcing Additional Exercise of Over-Allotment Option
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Draganfly Up Near 13% In US Pre-market After Announcing Additional Exercise of Over-Allotment Option
Jun 9, 2025 4:39 AM

07:29 AM EDT, 06/09/2025 (MT Newswires) -- Draganfly ( DPRO ) , a drone-solutions, and systems developer, was at last look up near 13% in U.S.- pre-market trading after the company over the weekend said further to the closing of its US$3.6 million underwritten public offering on May 5, Maxim Group, partially exercised their over-allotment option to buy additional common shares.

Maxim bought an additional 100,000 common shares at US$2.09 per share for US$209,000 prior to deducting underwriter discounts and commissions.

As previously announced, Draganfly ( DPRO ) intends to use the net proceeds from the offering for general corporate purposes, including to fund its capabilities to meet demand for its new products including growth initiatives and/or for working capital requirements including the continuing development and marketing of the company's core products, potential acquisitions and research and development.

U.S.-listed shares of the company were last seen up $0.38 at $3.350 in pre-market trading. This comes after the stock jumped 22% in regular hours on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Agilent Technologies' MAGE-A4 Test Approved by FDA for Use With T-Cell Receptor Therapy
Agilent Technologies' MAGE-A4 Test Approved by FDA for Use With T-Cell Receptor Therapy
Aug 2, 2024
11:19 AM EDT, 08/02/2024 (MT Newswires) -- Agilent Technologies ( A ) said Friday that the US Food and Drug Administration has approved its MAGE-A4 IHC 1F9 pharmDx as a diagnostic tool for identifying synovial sarcoma patients who may be treated with Adaptimmune Therapeutics' ( ADAP ) Tecelra, a MAGE-A4-directed engineered T-cell Receptor therapy. MAGE-A4, or melanoma-associated antigen A4, is...
Roku to See Continued Growth Following Solid Q2, Macquarie Says
Roku to See Continued Growth Following Solid Q2, Macquarie Says
Aug 2, 2024
11:24 AM EDT, 08/02/2024 (MT Newswires) -- Roku ( ROKU ) is expected to see continued growth after reporting solid results for Q2, with revenue and adjusted earnings before interest, taxes, depreciation and amortization topping market expectations, Macquarie said in a note Friday. The Q2 revenue beat came from both the devices and the platform side, the firm said. Roku...
Auto Parts Manufacturer Magna Shares Slide On Q2 Earnings Miss, Outlook Cut: Details
Auto Parts Manufacturer Magna Shares Slide On Q2 Earnings Miss, Outlook Cut: Details
Aug 2, 2024
Magna International, Inc. ( MGA ) shares are trading lower after reporting second-quarter results. The company reported adjusted earnings per share of $1.35, which missed the street view of $1.44. Quarterly sales of $10.958 billion also missed the analyst consensus of $11.012 billion. Sales were negatively impacted by the end of production of certain programs, lower Complete Vehicle assembly volumes,...
DOJ faces Friday deadline on TikTok children privacy suit
DOJ faces Friday deadline on TikTok children privacy suit
Aug 2, 2024
WASHINGTON (Reuters) - The U.S. Justice Department faces a Friday deadline to decide whether to sue TikTok and parent company ByteDance for failing to protect children's privacy on the social media app. In June, the Federal Trade Commission referred a complaint against the social media platform TikTok and China's ByteDance over potential violations of children's privacy to the Justice Department....
Copyright 2023-2026 - www.financetom.com All Rights Reserved